Live Breaking News & Updates on Julien Seneschal

Stay updated with breaking news from Julien seneschal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vitiligo: 'Impressive' Results for Povorcitinib, Baricitinib

Substantial facial and total body repigmentation in patients with nonsegmental vitiligo was achieved in separate trials of povorcitinib and baricitinib plus phototherapy. ....

United Kingdom , France General , Leo Pharma , Reinhart Speeckaert , Zenas Yiu , Khaled Ezzedine , Eli Lilly , Pierre Fabre , University Of Bordeaux , European Academy Of Dermatology , National Reference Center , Area Of Research , Ghent University Hospital , Incyte Corporation , University Of Manchester , European Academy , Facial Vitiligo Area Scoring Index , Drug Administration , European Medicines Agency , Medscape Medical News , Povorcitinib Phase , Henri Mondor Hospital , Val De Marne , Julien Seneschal , Rare Skin Diseases , Vitiligo Extent Score ,

Topical Ruxolitinib for Vitiligo: First-Year Experiences

Some dermatologists recommend combining the treatment with phototherapy and advise that results can take many months to see. ....

Temple University , United States , New York University , New York , Northwestern University , Candrice Heath , David Rosmarin , Upadacitinib Rinvoq , Daniel Gutierrez , Raj Chovatiya , Drug Administration , Department Of Dermatology At Indiana University , University Of Bordeaux , World Congress , York University , Experiences With Payers , Safety Net Hospital , Medscape Medical News , Spotlight Success , Vitiligo Area Scoring Index , Julien Seneschal , New York City , Indiana University , Practice Management , Cosmetic Dermatology , Atopic Dermatitis ,

Ruxolitinib Response in Teens, Adults With Vitiligo Compared

Pooled data from the phase 3 TRuE-V1 and TRuE-V2 studies were used to evaluate responses in a subset of adolescents treated with the topical JAK inhibitor for vitiligo. ....

Shital Poojary , Drug Administration , University Of Bordeaux , European Medicines Agency , Research Center , World Congress , Vitiligo Area Scoring Index , Julien Seneschal , Steady Improvement , Medscape Medical News , Presented July , Adolescent Medicine , Acne Vulgaris , Practice Management , Patient Safety , Adverse Effects , Side Effects , Autoimmune Disease , Clinical Research , Clinical Trials , Linical Studies , Us Food And Drug Administration , Nited States Food And Drug Administration ,